LivaNova PLC Ordinary Shares (LIVN)
LivaNova PLC is a global medical device company specializing in innovative solutions for cardiac and neurological conditions. Founded in 2018 through the merger of Sorin Group and Cyberonics, the company focuses on developing and manufacturing devices for cardiac surgery, neuromodulation, and neurocritical care, aiming to improve patient outcomes and quality of life.
Company News
The global magnetic ablation catheters market is expected to grow significantly, reaching $1.1 billion by 2035, driven by advancements in technology and the rising prevalence of cardiovascular diseases. Key factors driving growth include the increasing adoption of minimally invasive procedures and continued investment in healthcare infrastructure...
LivaNova (LIVN) delivered earnings and revenue surprises of 62.22% and 6.45%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Sportradar Group AG (NASDAQ: SRAD) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million share repurchase program. Sportradar posted quarterly earnings of 8 cents pe...
David Einhorn's GLRE 13F stock portfolio value increased from $1.49B to $1.75B this quarter. The largest 3 positions are at ~48% of the portfolio.
LIVN earnings call for the period ending September 30, 2021.